Eureka Forbes Limited has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The company reported robust operational performance while highlighting strategic leadership changes. Furthermore, the Board of Directors approved the appointment of new auditors for the 2026-27 financial year, ensuring continued governance and operational transparency as the firm advances its market position in the health and hygiene sector.
Financial Performance Highlights
For the financial year ended March 31, 2026, Eureka Forbes recorded a standalone revenue from operations of ₹2,71,046.92 lakh, compared to ₹2,43,606.24 lakh in the previous year. The standalone profit after tax stood at ₹16,020.70 lakh. On a consolidated basis, the company achieved annual revenue of ₹2,70,906.14 lakh with a consolidated profit after tax of ₹16,262.37 lakh for the same period.
Strategic Leadership Update
The company announced an enhancement in the leadership role of Mr. Anurag Kumar, Chief Growth Officer. Effective May 19, 2026, Mr. Kumar will assume additional responsibility for the company’s E-commerce and D2C divisions. Mr. Kumar brings over 28 years of industry experience, having previously held significant roles at major global organizations, which is expected to bolster the company’s digital-first growth strategy.
Governance and Audits
In accordance with statutory requirements for the 2026-27 financial year, the Board has approved the appointment of new professional firms to oversee financial health and compliance:
- Cost Audit: M/s. J. Chandra & Associates has been appointed as Cost Auditor.
- Internal Audit: M/s. PricewaterhouseCoopers Services LLP (PwC) has been appointed to conduct internal audits, focusing on governance, risk management, and operational efficiency.
Operational Context
The company noted an exceptional impact of ₹4,044.18 lakh during the year, resulting from the implementation of new labor codes, which has been accounted for as an exceptional item. Management continues to monitor ongoing regulatory developments to ensure full compliance while maintaining a sharp focus on its primary business of health and hygiene solutions.
Source: BSE
